Recap: Ocular Therapeutix Q2 Earnings

Ocular Therapeutix OCUL reported its Q2 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Ocular Therapeutix missed estimated earnings by 8.7%, reporting an EPS of $-0.25 versus an estimate of $-0.23.

Revenue was up $548 thousand from the same period last year.

Last quarter the company beat on EPS by $0.04 which was followed by a 1.84% increase in the share price the next day.

Here's a look at Ocular Therapeutix's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.26	-0.23	-0.26	-0.21
EPS Actual	-0.22	-0.23	-0.23	-0.25
Revenue Estimate	14.20M	14.44M	12.45M	11.60M
Revenue Actual	13.19M	12.31M	12.15M	11.72M

To track all earnings releases for Ocular Therapeutix visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar